Valuation: PharmaEssentia Corporation

Market Cap 474B 14.64B 12.88B 11.96B 11B 20.63B 1,418B 21B 143B 55.8B 692B 54.97B 53.78B 2,399B P/E 2026 *
44.2x
P/E 2027 * 32.1x
Enterprise Value 448B 13.82B 12.16B 11.29B 10.39B 19.48B 1,339B 19.83B 135B 52.68B 653B 51.89B 50.77B 2,265B EV / Sales 2026 *
17.9x
EV / Sales 2027 * 12.7x
Free-Float
75.37%
Yield 2026 *
0.08%
Yield 2027 * 0.13%
1 day-2.54%
1 week-8.73%
Current month-4.80%
1 month+16.50%
3 months+102.81%
6 months+112.61%
Current year+171.42%
1 week 1,125
Extreme 1125
1,235
1 month 1,032.2
Extreme 1032.2031
1,415.34
Current year 423.7
Extreme 423.6991
1,415.34
1 year 395.61
Extreme 395.6133
1,415.34
3 years 222.58
Extreme 222.5833
1,415.34
5 years 56.05
Extreme 56.052
1,415.34
10 years 43.54
Extreme 43.5418
1,415.34
Manager TitleAgeSince
Chief Executive Officer - 01/01/2003
Director of Finance/CFO - 14/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 01/09/2003
Director/Board Member - -
Director/Board Member - 30/06/2009
Change 5-day change 1-year change 3-year change Capi.($)
-2.54%-8.73%+164.11%+289.45% 15B
+1.23%+0.35%+51.62%+87.98% 55.27B
+5.09%+6.24%+63.15%+62.06% 54.15B
+0.72%-0.05%+3.84%+409.54% 23.11B
+0.25%+0.55%-19.67%-15.22% 23.22B
+1.03%-0.20%+36.49%-3.59% 20.33B
-0.37%+0.71%+31.36%-31.61% 17.91B
+0.87%-0.19%+39.07%+600.00% 15.76B
+1.22%-0.05%+22.58%+182.63% 13.82B
+1.06%-0.40%+77.13%+151.84% 12.4B
Average +0.86%+0.60%+46.97%+173.31% 25.1B
Weighted average by Cap. +1.54%+2.62%+46.03%+139.06%

Financials

2026 *2027 *
Net sales 25.07B 774M 681M 633M 582M 1.09B 74.98B 1.11B 7.56B 2.95B 36.57B 2.91B 2.84B 127B 34.57B 1.07B 939M 872M 802M 1.5B 103B 1.53B 10.43B 4.07B 50.43B 4.01B 3.92B 175B
Net income 10.85B 335M 295M 274M 252M 472M 32.46B 481M 3.28B 1.28B 15.83B 1.26B 1.23B 54.94B 14.97B 462M 407M 378M 347M 652M 44.78B 663M 4.52B 1.76B 21.84B 1.74B 1.7B 75.77B
Net Debt -26.52B -819M -720M -669M -616M -1.15B -79.33B -1.18B -8B -3.12B -38.7B -3.08B -3.01B -134B -34.73B -1.07B -943M -876M -806M -1.51B -104B -1.54B -10.48B -4.09B -50.66B -4.03B -3.94B -176B
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
23/07/26 NT$1,150.00 -2.54% 2,928,191
22/07/26 NT$1,180.00 +0.43% 2,030,357
21/07/26 NT$1,175.00 0.00% 2,044,851
20/07/26 NT$1,175.00 -1.67% 2,926,691
17/07/26 NT$1,195.00 -5.16% 3,377,763
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,150.00TWD
Average target price
1,073.31TWD
Spread / Average Target
-6.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock